WW · WW International, Inc.

The committee appointments reflect a deliberate reinforcement of board expertise across critical governance domains: Ms. Gavales’ dual assignment supports oversight of executive compensation design and strategic capital allocation, while Ms. Gove’s roles on the Audit and Nominating Committees strengthen financial controls and board refreshment processes. Notably, the Board explicitly affirmed the existing Office of the CEO structure — comprising the CFO and COO — as sufficient to maintain operational and strategic continuity during the CEO search, declining to name an interim leader. This decision underscores confidence in the current leadership team’s ability to execute near-term priorities, including integration of GLP-1 era offerings and expansion of employer/health plan partnerships. The engagement of a leading executive search firm signals rigor and external validation in identifying a permanent CEO aligned with the company’s science-backed, technology-integrated weight management mission. While not a material corporate event like a transaction or earnings release, this governance update provides investors with clarity on board composition, leadership stability, and the pace and process of executive succession.